Effect of 4-methylthiobenzoic acid on cisplatin-induced ototoxicity in the rat

Hearing Research

Volumn 131, Issue 1-2, 1999, Pages 117-127

  Kamimura, Takao ^a   Whitworth, Craig A ^a   Rybak, Leonard P ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

4 Methylthiobenzoic acid; Auditory brainstem response; Cisplatin; Ototoxicity; Scanning electron microscopy

Indexed keywords

BENZOIC ACID DERIVATIVE; CISPLATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUDITORY THRESHOLD; CELL LOSS; CLICK; COCHLEA; CONTROLLED STUDY; CORTI ORGAN; DRUG EFFECT; EAR PROTECTION; EVOKED BRAIN STEM AUDITORY RESPONSE; HAIR CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY;

ANIMALS; BENZOIC ACIDS; BODY WEIGHT; CELL COUNT; CISPLATIN; COCHLEA; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; HAIR CELLS; MALE; MICROSCOPY, ELECTRON, SCANNING; ORGAN OF CORTI; RATS; RATS, WISTAR;

EID: 0032955792     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5955(99)00017-9     Document Type: Article

References (46)

1. Böhmer A. The Preyer reflex - an easy estimate of hearing function in guinea pigs. Acta Otolaryngol. (Stockh.). 106:1988;368-372.
2. Boogaard P.J., Lempers E.L., Mulder G.J., Meerman J.H.N. 4-Methylthiobenzoic acid reduces cisplatin nephrotoxicity in rats without compromising anti-tumor activity. Biochem. Pharmacol. 41:1991;1997-2003.
3. Brock P.R., Bellman S.C., Yeomans E.C., Pinkerton C.R., Pritchard J. Cisplatin ototoxicity in children: a practical grading system. Med. Pediatr. Oncol. 19:1991;295-300.
4. Campbell K.C.M., Rybak L.P., Meech R.P., Hughes L. D-Methionine provides excellent protection from cisplatin ototoxicity. Hear. Res. 102:1996;90-98.
5. Church M.W., Kaltenbach J.A., Blakley B.W., Burgio D.L. The comparative effect of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity. Hear. Res. 86:1995;195-203.
6. Clerici W.J., Hensley K., DiMartino D.L., Butterfield D.A. Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear. Res. 98:1996;116-124.
7. Di Re F., Bohm S., Oriana S., Spatti G.B., Pirovano C., Tedeschi M., Zunino F. High-dose cisplatin and cyclophosphamide with glutathione in the treatment of advanced ovarian cancer. Ann. Oncol. 4:1993;55-61.
8. Dobyan D.C., Bull J.M., Strebel F.R., Sunderland B.A., Bulger R.E. Protective effects of O-(β-hydroxyethyl)-rutoside on cis-platinum-induced acute renal failure in the rat. Lab. Invest. 55:1986;557-563.
9. Dormans J.A.M.A., Peters-Volleberg G.W.M., Dortant P.M., Speijers G.J.A. Ototoxicity of tobramycin in young adult and old rats. Toxicol. Appl. Pharmacol. 136:1996;179-185.
10. Frei B. Reactive oxygen species and antioxidant vitamins: mechanism of action. Am. J. Med. 97:1994;5S-13S.
11. Gabaizadeh R., Staecker H., Liu W., Kopke R., Malgrange B., Lefebvre P.P., Van de Water T.R. Protection of both auditory hair cells and auditory neurons from cisplatin induced damage. Acta Otolaryngol (Stockh.). 117:1997;232-238.
12. Hinojosa R., Riggs L.C., Strauss M., Matz G.J. Temporal bone of cisplatin ototoxicity. Am. J. Otol. 16:1995;731-740.
13. Hunter-Duvar I.M. A technique for preparation of cochlear specimens for assessment with the scanning electron microscope. Acta Otolaryngol. Suppl. (Stockh.). 351:1978;3-23.
14. Husain K., Morris C., Whitworth C., Trammel G.L., Rybak L.P., Somani S.M. 4-Methylthiobenzoic acid protection against cisplatin nephrotoxicity: antioxidant system. Fund. Appl. Toxicol. 32:1996;278-284.
15. Jones M.M., Basinger M.A., Holscher M.A. Thioether suppression of cisplatin nephrotoxicity in the rat. Anticancer Res. 11:1991;449-453.
16. Kaltenbach J.A., Church M.W., Blakley B.W., McCaslin D.L., Burgio D.L. Comparison of five agents in protecting the cochlea against the ototoxic of cisplatin in the hamster. Otolaryngol. Head Neck Surg. 117:1997;493-500.
17. Kimitsuki T., Nakagawa T., Hisashi K., Komune S., Komiyama S. Cisplatin blocks machano-electric transducer current in chick cochlear hear cells. Hear. Res. 71:1993;64-68.
18. Konishi T., Gupta B., Prazma J. Ototoxicity of cis-dichlorodiammine platinum (II) in guinea pig. Am. J. Otolaryngol. 4:1983;18-26.
19. Kopelman J., Budnick A.S., Sessions R.B., Kramer M.B., Wong G.Y. Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing. Laryngoscope. 98:1988;858-864.
20. Kopke R.D., Liu W., Gabaizadeh R., Jacono A., Feghali J., Spray D., Garacia P., Steinman H., Malgrange B., Ruben R.J., Rybak L., Van de Water T.R. Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hear cells. Am. J. Otol. 18:1997;559-571.
21. Laurell G., Bagger-Sjöbäck D. Degeneration of the organ of Corti following intravenous administration of cisplatin. Acta Otolaryngol. (Stockh.). 111:1991;891-898.
22. Laurell G., Bagger-Sjöbäck D. Dose-dependent inner ear changes after I.V. administration of cisplatin. J. Otolaryngol. 20:1991;158-167.
23. Liberman M.C. The cochlea frequency map for the cat: labeling auditory nerve fibers of known characteristic frequency. J. Acoust. Soc. Am. 72:1982;1441-1449.
24. Malick L.E., Wilson R.B. Modified thiocarbohydrazide procedure for scanning electron microscopy: routine use for normal, pathological, or experimental tissues. Stain Technol. 50:1975;265-269.
25. Möller M. Frequency representation in the rat cochlea. Hear. Res. 51:1991;247-254.
26. Nakai Y., Konishi K., Chang K.C., Ohashi K., Morisaki N., Minowa Y., Morimoto A. Ototoxicity of the anticancer drug cisplatin. An experimental study. Acta Otolaryngol. 93:1982;227-232.
27. Otto W.C., Brown R.D., Gage-White L., Kupetz S., Anniko M., Penny J.E., Henley C.M. Effect of cisplatin and thiosulfate upon auditory brainstem responses of guinea pigs. Hear. Res. 35:1988;79-85.
28. Pasic T.R., Dobie R.A. Cis-platinum ototoxicity in children. Laryngoscope. 101:1991;985-991.
29. Ravi R., Somani S.M., Rybak L.P. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol. Toxicol. 76:1995;386-394.
30. Robertson D. Horseradish peroxidase injection of physiologically characterized afferent and efferent neurons in the guinea pig spiral ganglion. Hear. Res. 15:1984;113-121.
31. Rubin J.S., Wadler S., Beitler J.J., Haynes H., Rozenblet A., McGill F., Goldberg G., Runowicz C. Audiological findings in a phase I protocol investigating the effect of WR 2721, high-dose cisplatin and radiation therapy in patients with lacally advanced cervical cartinoma. J. Laryngol. Otol. 109:1995;744-747.
32. Rybak L.P. Cis-platinum associated hearing loss. J. Laryngol. Otol. 95:1981;745-747.
33. Rybak L.P., Ravi R., Somani S.M. Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: antioxidant system. Fund. Appl. Toxicol. 26:1995;293-300.
34. Rybak L.P., Husain K., Evanson L., Morris C., Whitworth C., Somani S.M. Protection by 4-methylthiobenzoic acid against cisplatin-induced ototoxicity: antioxidant system. Pharmacol. Toxicol. 81:1997;173-179.
35. Rybak, L.P., Husain, K., Morris, C., Whitworth, C., Somani, S., 1998. Effect of protective agents against cisplatin ototoxicity. Am. J. Otol. (in press).
36. Saito T., Moataz R., Dulon D. Cisplatin blocks depolarization-induced calcium entry in isolated cochlear outer hear cells. Hear. Res. 56:1991;143-147.
37. Saito T., Yamada T., Manabe Y., Yamamoto T., Saito H. Cisplatin metabolites and their toxicity on isolated cochlear outer hair cells in vitro. Acta Otolaryngol. (Stockh.). 116:1996;561-565.
38. Saito T., Zhang Z.J., Manabe Y., Ohtsubo T., Saito H. The effect of sodium thiosulfate on ototoxicity and pharmacokinetics after cisplatin treatment in guinea pigs. Eur. Arch. Otorhinolaryngol. 254:1997;281-286.
39. Schweitzer V.G. Cisplatin-induced ototoxicity: effect of pigmentation and inhibitory agents. Laryngoscope. 103:1993;1-52.
40. Schweitzer V.G. Ototoxicity of chemotherapeutic agents. Otolaryngol. Clin. N. Am. 26:1993;759-789.
41. Schweitzer V.G., Dolan D.F., Abrams G.E., Davidson T., Synder R. Amelioratin of cisplatin-induced ototoxicity by fosfomycin. Laryngoscope. 96:1986;948-958.
42. Stengs C.H.M., Klis S.F.L., Huizing E.H., Smoorenburg G.F. Cisplatin-induced ototoxicity; electrophysiological evidence of spontaneous recovery in the albino guinea pig. Hear. Res. 111:1997;103-113.
43. Tange R.A., Conijin E.A.J.G., Van Zeijl L.G.P.M. The cortitoxic effect of cis-platinum in the guinea pig. Arch. Otorhinolaryngol. 237:1982;17-26.
44. Vater M., Feng A.S., Betz M. An HRP-study on the frequency place map of the horseshoebat cochlea: Morphological correlates of the sharp tuning to a narrow frequency band. J. Comp. Physiol. A. 157:1985;671-686.
45. Vermorken J.B., Kapteijn T.S., Hart A.A.M., Pinedo H.M. Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration. Eur. J. Cancer Clin. Oncol. 19:1983;53-58.
46. Walker M.E. Jr., Fazekas-May A.M., Heard W.K., Yee S., Montague D., Jones M.M. Prevention of cisplatin-induced toxicity by selected dithiocarbamates. Ann. Clin. Lab. Sci. 24:1994;121-133.